Lloyd Johnston's most recent trade in Selecta Biosciences Inc was a trade of 6,381 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Jan. 4, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 6,381 | 268,918 (0%) | 0% | 1.1 | 7,234 | Common Stock |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 3,372 | 265,535 (0%) | 0% | 1.1 | 3,808 | Common Stock |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 04 Jan 2023 | 20 | 265,515 (0%) | 0% | 1.1 | 22 | Common Stock |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 04 Jan 2023 | 11 | 268,907 (0%) | 0% | 1.2 | 13 | Common Stock |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 475,000 | 475,000 | - | - | Employee Stock Option (right to buy) | |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 100,000 | 275,299 (0%) | 0% | 0 | Common Stock | |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 3.09 per share. | 05 Jan 2022 | 3,416 | 175,299 (0%) | 0% | 3.1 | 10,541 | Common Stock |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 340,000 | 340,000 | - | - | Employee Stock Option (right to buy) | |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 72,000 | 178,715 (0%) | 0% | 0 | Common Stock | |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 10 Dec 2021 | 4,370 | 106,715 (0%) | 0% | 3.0 | 13,053 | Common Stock |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 13,750 | 111,085 (0%) | 0% | 0 | Common Stock | |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 13 Oct 2021 | 3,892 | 97,335 (0%) | 0% | 4.4 | 17,086 | Common Stock |
Selecta Biosciences Inc | Lloyd Johnston | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 13,750 | 101,227 (0%) | 0% | 0 | Common Stock | |
Selecta Biosciences Inc | Lloyd Johnston | COO and SVP, R&D | Sale of securities on an exchange or to another person at price $ 4.45 per share. | 17 Mar 2021 | 15,128 | 87,477 (0%) | 0% | 4.4 | 67,312 | Common Stock |
Selecta Biosciences Inc | Lloyd Johnston | COO and SVP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2021 | 44,871 | 0 | - | - | Employee Stock Option (right to buy) | |
Selecta Biosciences Inc | Lloyd Johnston | COO and SVP, R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. | 11 Feb 2021 | 44,871 | 102,605 (0%) | 0% | 0.6 | 28,269 | Common Stock |
Selecta Biosciences Inc | Lloyd Johnston | COO and SVP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 230,000 | 230,000 | - | - | Employee Stock Option (right to buy) | |
Selecta Biosciences Inc | Lloyd Johnston | COO and SVP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 38,000 | 57,734 (0%) | 0% | 0 | Common Stock | |
Selecta Biosciences Inc | Lloyd Johnston | COO & SVP, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |